Last reviewed · How we verify
ESHAP-Imatinib
At a glance
| Generic name | ESHAP-Imatinib |
|---|---|
| Sponsor | Pusan National University Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ESHAP-Imatinib CI brief — competitive landscape report
- ESHAP-Imatinib updates RSS · CI watch RSS
- Pusan National University Hospital portfolio CI